Pharmaceutical

Filter

Current filters:

None

Popular Filters

55 to 79 of 7221 results

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Fujifilm's favipiravir performs well in early-stage Ebola study

Fujifilm's favipiravir performs well in early-stage Ebola study

25-02-2015

A study conducted in Guinea has shown that Fujifilm’s favipiravir halves mortality rates in patients…

Antibiotics and Infectious diseasesfavipiravirFujifilmGuineaPharmaceuticalResearch

Takeda consolidates business in Singapore, opening new office

Takeda consolidates business in Singapore, opening new office

25-02-2015

Japanese drug major Takeda has opened its new office in Biopolis, Singapore. The space will host its…

PharmaceuticalProductionResearchSingaporeTakeda PharmaceuticalsVaccines

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

24-02-2015

Despite a high rate of attrition, there is a considerable level of commercial interest in the Alzheimer’s…

AlzheimerGBI ResearchNeurologicalPharmaceuticalResearch

30% increase in R&D projects for neglected diseases in 2014; report

24-02-2015

Trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released…

GlobalPharmaceuticalResearchTropical diseases

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Ferring acquires novel drug delivery technology from CTCBIO

24-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has signed an agreement with CTCBIO…

CTCBIOFerring PharmaceuticalsLicensingPharmaceutical

Aquavit to invest in biopharma R&D and manufacturing in South Korea

24-02-2015

Aquavit Life Sciences, the South Korea-based subsidiary of privately-held US firm Aquavit Pharmaceuticals,…

AquavitPharmaceuticalProductionResearchSouth Korea

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

24-02-2015

The Medicines Patent Pool has announced a license with US pharma giant Merck & Co for pediatric formulations…

Anti-viralsMerck & CoPharmaceuticalProductionRaltegravir Tablets

US FDA approves Novartis’ Farydak, the first HDAC inhibitor for MM patients

24-02-2015

The US Food and Drug Administration yesterday approved Swiss pharma giant Novartis’ Farydak (panobinostat,…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

Eli Lilly delays US and Europe filings for new diabetes agent peglispro

23-02-2015

US pharma major Eli Lilly says it is delaying the submission of its basal insulin peglispro (BIL) to…

DiabetesEli LillyEuropepeglisproPharmaceuticalRegulationUSA

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

Advagraf plus basiliximab results in significantly better renal function

23-02-2015

Data published last week in the American Journal of Transplantation demonstrate that in liver transplant…

AdvagrafAstellas PharmaBasiliximabNephrology and HepatologyPharmaceuticalResearch

Valeant fourth-qtr 2014 earnings beat expectations

Valeant fourth-qtr 2014 earnings beat expectations

23-02-2015

Canada’s Valeant Pharmaceutical International posted financial results late Sunday, showing that fourth-quarter…

FinancialPharmaceuticalValeantValeant Pharmaceutical InternationalValeant Pharmaceuticals International

Almirall reports strong 2014 financial results following AstraZeneca transfer

Almirall reports strong 2014 financial results following AstraZeneca transfer

23-02-2015

Almirall, Spain’s largest drugmaker, has continued its upward trend and reported strong results for…

AlmirallEkliraFinancialPharmaceuticalSativexSpain

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

23-02-2015

A Phase IIb study of dupilumab, from Sanofi and Regeneron, has shown that the drug improved patient-reported…

DermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

Report: Cutting pharmacies in Russia could benefit patients

23-02-2015

A reduction in the number of pharmacies in Russia could lead to cheaper drug prices for patients, according…

KazakhstanMarkets & MarketingMedicinal chemistryPharmaceuticalPharmacistRussiaUkraine

Access to medicines: evolving the European debate

Access to medicines: evolving the European debate

23-02-2015

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the debate…

EuropeHealthcarePharmaceuticalPoliticsPricing

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

55 to 79 of 7221 results

Back to top